In addition, to further confirm that TPD52L2 is an oncogene, this study included five data sets of E-MTAB-1980, GSE22541, GSE40912, ICGC-ccRCC, and TCGA-ccRCC for meta-analysis of 791 ccRCC. This evidence concerns the gene TPD52L2 and nonpapillary renal cell carcinoma.